PHP
ARDX icon

Parkman Healthcare Partners’s Ardelyx ARDX Stock Holding History

Parkman Healthcare Partners’s Portfolio ARDX Stock Details ARDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-301,086
Closed -$1.18M – 94
2025
Q2 		$1.18M Buy
301,086
+91,505
+44% +$377K 0.14% 83
2025
Q1 		$1.03M Buy
209,581
+31,787
+18% +$171K 0.12% 85
2024
Q4 		$901K Buy
177,794
+50,854
+40% +$281K 0.12% 83
2024
Q3 		$875K Sell
126,940
-23,252
-15% -$137K 0.11% 86
2024
Q2 		$1.11M Sell
150,192
-49,808
-25% -$350K 0.15% 79
2024
Q1 		$1.46M Buy
+200,000
New +$1.71M 0.18% 89

Other funds holding ARDX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Parkman Healthcare Partners's ARDX Position: Q3 2025 in Review

Parkman Healthcare Partners sold out of Ardelyx (ARDX) in Q3 2025, closing a stake of 301,086 shares — an estimated $1.18M sold.

Parkman Healthcare Partners first reported a position in ARDX in Q1 2024 and held it in 6 quarters. The position peaked at $1.46M in Q1 2024. 223 funds tracked by Wall St. Rank hold ARDX as of Q3 2025.

  • Parkman Healthcare Partners reported no remaining Ardelyx position as of Q3 2025 after selling out during the quarter.
  • Parkman Healthcare Partners sold 301,086 Ardelyx shares in Q3 2025, an estimated $1.18M.
  • Parkman Healthcare Partners first reported a position in Ardelyx in Q1 2024 and held it in 6 quarters.
  • Parkman Healthcare Partners's Ardelyx position peaked at $1.46M in Q1 2024.
  • 223 funds tracked by Wall St. Rank held Ardelyx as of Q3 2025.

Based on Parkman Healthcare Partners's 13F filing for Q3 2025, filed 14 Nov 2025.